Status:
COMPLETED
Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction
Lead Sponsor:
Luzerner Kantonsspital
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Silent ischemia has been shown to negatively affect prognosis in patients after myocardial infarction. However, long-term outcome data in totally asymptomatic patients is missing and it is unknown whe...
Detailed Description
Silent ischemia has been shown to negatively affect prognosis in patients after myocardial infarction (MI). Despite these consistent findings, there are almost no prospective data unequivocally docume...
Eligibility Criteria
Inclusion
- Recent myocardial infarction within last 3 months
- Documented silent myocardial ischemia (type I)
Exclusion
- Symptomatic myocardial ischemia
Key Trial Info
Start Date :
June 1 1991
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00387231
Start Date
June 1 1991
End Date
May 1 2006
Last Update
October 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Hospital Lucerne
Lucerne, Canton of Lucerne, Switzerland, 6000